

Selenocysteine, selenomethionine, selenate, selenite
Selenium, an essential dietary trace mineral, is an important component of antioxidant systems such as glutathione peroxidase (1) that neutralize and protect against damage caused by free radicals and reactive oxygen species. It also plays an important role in thyroid function. Selenium can be obtained from the diet by consuming whole grains, meats, seafood, poultry and nuts. It is also marketed as a supplement to boost immune function and for prevention of cardiovascular, rheumatic diseases, and cancer.
Several studies have been conducted to determine the role of selenium in reducing the risk of cardiovascular disease but data are inconclusive (23) (28).
Selenium supplementation was found to reduce the viral load in individuals infected with human immunodeficiency virus (HIV) (19). Studies also indicate that selenium may improve glucose metabolism but it was not useful in preventing type 2diabetes and in some cases may increase the risk (20) (21).
The importance of selenium in cancer prevention has been documented in epidemiological studies and clinical intervention trials. Data suggest its benefits in preventing gastrointestinal (16), lung (17) and bladder cancers (26). Selenium supplementation resulted in significant reduction of side effects including hair loss, abdominal pain, and loss of appetite in ovarian cancer patients undergoing chemotherapy (15). It was also effective in reducing head and neck lymphedema (12) (14) and diarrhea associated with radiation therapy (24).
However, the large prevention study SELECT (Selenium and Vitamin E Cancer Prevention Trial) (8), based on previous data indicating that selenium and vitamin E reduced the incidence of prostate cancer, did not find evidence of protective effects of selenium. The trial was suspended in January 2009, when initial data analysis showed no reduction in the risk of prostate cancer with selenium alone or with vitamin E (21). Another study showed selenium, when used together with soy and Vitamin E, did not prevent prostate cancer progression (27). Moreover, results from a cross-sectional analysis of men with prostate cancer indicate that selenium levels may influence the risk of aggressive prostate cancer (22). Further, a review of randomized controlled trials did not find any evidence of selenium’s cancer preventive potential (29).
A chemoprevention trial of selenium in patients with NSCLC (nonsmall-cell lung cancer) was also halted after interim analysis as data did not show any benefit of selenium supplementation; there was an increase in secondary lung cancers in selenium users, although it was statistically insignificant (25).
Long-term use of selenium may also increase the risk of certain types of skin cancer (13).
Selenium is an essential structural element of the antioxidant enzyme glutathione-peroxidase that converts aggressive oxidation products and intracellular free radicals into less reactive or neutral components (3). Other biological functions of selenium include regulation of thyroid hormone action and regulation of the reduction status of vitamin C (2).
Absorption:
Absorption of selenium is efficient and not regulated. More than 90 percent of selenomethionine, the major dietary form of the element, is absorbed by the same mechanism as methionine itself. Selenocysteine appears to be absorbed very well also. Of the inorganic forms, selenate is almost completely absorbed, but with a significant fraction lost in the urine before incorporation into tissue. Selenite has a more variable absorption probably related to interactions with substances in the gut lumen, but it is better retained, once absorbed, than selenate. Absorption of selenite is generally greater than 50 percent. Selenate and selenite are not major dietary constituents, but are commonly used to fortify foods and as selenium supplements.
Distribution:
Selenomethionine enters the methionine pool in the body and shares the fate of methionine until catabolized by the transsulfuration pathway ultimately leading to the reduced form.
Metabolism / Excretion:
Ingested selenocysteine, selenate, and selenite are all apparently metabolized by methylation to selenide. The selenide can be metabolized to selenophosphate, the precursor of selenocysteine in selenoproteins. The mechanism that regulates production of excretory metabolites has yet to be elucidated. The excretory metabolites appear in the urine primarily.
(2)
Case Report: Oral consumption of 10 g of sodium selenite supplement for treatment of prostate cancer resulted in the death of a 75-year-old man (18).
Chronic selenosis (doses greater than 1000 mcg/day): Muscle weakness, fatigue, peripheral neuropathy, dermatitis, nail and hair changes/loss, garlic breath/body odor, irritability, growth retardation, hepatic necrosis
Toxicity: Acute toxicity via selenium poisoning has occurred with either accidental or suicidal ingestion of gun blueing solution or sheep drench. Consumption of gram quantities of selenium can cause severe gastrointestinal disturbance, neurological disturbance, acute respiratory distress syndrome, myocardial infarction, and renal failure.
(2) (5)
Supplement Interactions: High doses of selenium may decrease vitamin C absorption.
(5)
Clark LC, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 1996;276:1957-63.
A prospective, randomized evaluation of skin cancer prevention for patients with a history of either basal cell or squamous cell carcinoma. 1312 patients were randomized to receive either selenium 200 mcg or a placebo daily and return to the clinic every 6 months for follow-up evaluation. Enrollment began in 1983 and was completed December 1993. The only adverse event involved gastrointestinal disturbances that lead to the withdrawal of consent in 21 selenium patients and 14 placebo. No chronic selenosis was noted. A total of 8271 person-years of follow-up was accumulated and indicated no significant difference between treatment groups on the recurrence of squamous or basal cell carcinomas. The authors did note that there was a statistically significant reduced relative risk of carcinoma incidence (lung, colorectal, prostate) for patients receiving selenium, however additional studies are need to validate.
Duffield-Lillico AJ, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst. 2003 Oct 1;95
In a followup analysis of the above trial, researchers summarized the entire blinded treatment period through January 1996 consisting of 9904 person-years. At this stage of followup patients with a history of nonmelanoma skin cancer were seen to have an increase in the risk of squamous cell carcinoma and total nonmelanoma skin cancer when supplemented with 200 mcg selenium daily. Furthermore, nonmelanoma skin cancer patients who had elevated baseline plasma selenium concentrations seemed to gain no protection against other cancers by selenium supplementation.
Bottom Line: Selenium has not been shown to treat cancer or heart disease.
Selenium is an element obtained in the diet from Brazil nuts, seafood, meats, cereals and grains. It is an essential part of the antioxidant enzyme glutathione-peroxidase, which protects cells from damage and DNA from mutations. For this reason, it has been studied for the prevention of diseases that are caused by or aggravated by this type of cellular damage, including cancer, heart disease, and rheumatoid arthritis. Selenium is also necessary for proper function of the immune system, but it is not known whether higher-than-normal levels of selenium can stimulate the immune system. Long-term use of selenium may increase the risk of certain types of cancer.